Floatz logo

Thiotepa

NK-Cell Leukemia

St. Jude Children's Research HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the NK-Cell Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
The Affiliated Hospital of Xuzhou Medical University
Phase 2B
Anti-Thymoglobulin, Rabbit
St. Jude Children's Research Hospital
Phase 2CCC
Mesna
St. Jude Children's Research Hospital
Phase 2CCC
Anti-Cd56 Car T
The Affiliated Hospital of Xuzhou Medical University
Phase 2CCC
cd45ra-depleted dli
St. Jude Children's Research Hospital
Phase 2CCC

View all 21 →

Same molecule, other indications

Thiotepa is also rated in:

graft versus host diseaseDormant
BBB
Indicative ·
73 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
72 / 100
View asset →
juvenile myelomonocytic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →